Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.
Gould RL, Thompson BJ, Rawlinson C, Kumar P, White D, Serfaty MA, Graham CD, McCracken LM, Bursnall M, Bradburn M, Young T, Howard RJ, Al-Chalabi A, Goldstein LH, Lawrence V, Cooper C, Shaw PJ, McDermott CJ. Gould RL, et al. Among authors: bradburn m. BMC Neurol. 2022 Nov 15;22(1):431. doi: 10.1186/s12883-022-02950-5. BMC Neurol. 2022. PMID: 36380299 Free PMC article.
Supporting people with Motor Neuron Disease (MND) to make decisions about gastrostomy feeding tube placement: a survey of UK healthcare professionals' practice and beliefs.
White S, O'Cathain A, Halliday V, Bradburn M, McDermott CJ. White S, et al. Among authors: bradburn m. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):290-298. doi: 10.1080/21678421.2024.2314061. Epub 2024 Feb 9. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38337170 Free article.
STructured lifestyle education for people WIth SchizophrEnia (STEPWISE): mixed methods process evaluation of a group-based lifestyle education programme to support weight loss in people with schizophrenia.
Gossage-Worrall R, Hind D, Barnard-Kelly KD, Shiers D, Etherington A, Swaby L, Holt RIG; STEPWISE Research Group. Gossage-Worrall R, et al. BMC Psychiatry. 2019 Nov 13;19(1):358. doi: 10.1186/s12888-019-2282-5. BMC Psychiatry. 2019. PMID: 31722694 Free PMC article. Clinical Trial.
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA, Graham CD, McCracken LM, Goldstein LH, Al-Chalabi A, Orrell RW, Williams T, Noad R, Baker I, Faull C, Lambert T, Chhetri SK, Ealing J, Hanratty A, Radunovic A, Gunawardana N, Meadows G, Gorrie GH, Young T, Lawrence V, Cooper C, Shaw PJ, Howard RJ; COMMEND Collaboration Group. Gould RL, et al. Among authors: bradburn m. Lancet. 2024 Jun 1;403(10442):2381-2394. doi: 10.1016/S0140-6736(24)00533-6. Epub 2024 May 9. Lancet. 2024. PMID: 38735299 Free article. Clinical Trial.
Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life.
Keetharuth AD, Gould RL, McDermott CJ, Thompson BJ, Rawlinson C, Bradburn M, Bursnall M, Kumar P, Turton EJ, Tappenden P, White D, Howard RJ, Serfaty MA, McCracken LM, Graham CD, Al-Chalabi A, Goldstein LH, Lawrence V, Cooper C, Young T; COMMEND Collaboration Group. Keetharuth AD, et al. Among authors: bradburn m. Eur J Neurol. 2024 Apr 25:e16317. doi: 10.1111/ene.16317. Online ahead of print. Eur J Neurol. 2024. PMID: 38660985
190 results